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Abstract
Introduction
Buruli ulcer (BU) is a severe necrotizing human skin disease caused byMycobacterium
ulcerans. Clinically, presentation is a sum of these diverse pathogenic hits subjected to criti-
cal immune-regulatory mechanisms. Among them, autophagy has been demonstrated as a
cellular process of critical importance. Since microtubules and dynein are affected by myco-
lactone, the critical pathogenic exotoxin produced byM. ulcerans, cytoskeleton-related
changes might potentially impair the autophagic process and impact the risk and progres-
sion of infection.
Objective
Genetic variants in the autophagy-related genes NOD2, PARK2 and ATG16L1 has been
associated with susceptibility to mycobacterial diseases. Here, we investigated their associ-
ation with BU risk, its severe phenotypes and its progression to an ulcerative form.
Methods
Genetic variants were genotyped using KASPar chemistry in 208 BU patients (70.2% with
an ulcerative form and 28% in severe WHO category 3 phenotype) and 300 healthy
endemic controls.
Results
The rs1333955 SNP in PARK2 was significantly associated with increased susceptibility to
BU [odds ratio (OR), 1.43; P = 0.05]. In addition, both the rs9302752 and rs2066842 SNPs
in NOD2 gee significantly increased the predisposition of patients to develop category 3
(OR, 2.23; P = 0.02; and OR 12.7; P = 0.03, respectively, whereas the rs2241880 SNP in
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ATG16L1 was found to significantly protect patients from presenting the ulcer phenotype
(OR, 0.35; P = 0.02).
Conclusion
Our findings indicate that specific genetic variants in autophagy-related genes influence
susceptibility to the development of BU and its progression to severe phenotypes.
Author Summary
Buruli ulcer (BU) is a neglected tropical disease caused byMycobacterium ulcerans.
Because the exact trigger is still under investigation, current treatment options rely mostly
on the surgical excision of the affected site. There is therefore a pressing demand for
improved risk prediction and tailored treatment as well as for new drug targets. By resort-
ing to the largest case-control study reported to date, we show that genetic variation in the
autophagy-related genes NOD2, PARK2 and ATG16L1 influence the risk and course of BU
disease. Thus, our results provide crucial insights into the role of autophagy in the patho-
genesis of BU.
Introduction
Buruli ulcer (BU) is a severe necrotizing human skin disease caused byMycobacterium ulcer-
ans, representing the third most common mycobacteriosis worldwide [1]. At least 33 countries
from Africa, South America and Western Pacific, with tropical, subtropical and temperate cli-
mates, have reported BU [1]. Moreover, in 2014, 2200 new cases were reported in 12 of those
33 countries [1]. BU initiates as a small, painless, raised skin papule, nodule, plaque or oedema.
Later, destruction of the subcutaneous adipose tissue leads to collapse of the epidermis and for-
mation of a characteristic ulcer with undermined edges [1]. Advanced lesions display massive
tissue destruction induced by the action of the exotoxin mycolactone, a potent cytotoxic and
immunosuppressive polyketide-derived macrolide released byM. ulcerans [2]. Clinically, pre-
sentation is a sum of these diverse pathogenic hits subjected to critical, mainly local, immune-
regulatory mechanisms [3].
Among the many immunological mechanisms defining susceptibility to infection and its
progression, autophagy has been demonstrated as a cellular process of critical importance to
immunity to viral, bacterial and protozoan infections [4]. Autophagy is a regulated process
contributing to the innate control of intracellular pathogens by triggering the autodigestion of
cytoplasmic components and driving pathogen clearance. Autophagy is known to be depen-
dent on microtubule cytoskeleton and dynein-driven transport, with dynein playing a role in
the delivery of autophagosome contents to lysosomes during autophagosome-lysosome fusion
[4]. Since microtubules and dynein are affected by mycolactone [5], cytoskeleton-related
changes might potentially impair the autophagic process and impact the risk and progression
ofM. ulcerans infection.
The function of specific components of the autophagic machinery, namely nucleotide-bind-
ing oligomerization domain-containing 2 (NOD2), E3 ubiquitin-protein ligase parkin
(PARK2) and autophagy-related protein 16–1 (ATG16L1), has been associated with resistance
to several intracellular pathogens, includingM. tuberculosis [4]. Based on reports linking vari-
ants in these genes with defective activation of autophagy as well as our own data proposing a
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central role for autophagy in the intracellular control ofM. ulcerans infection through myco-
lactone-induced impairment of cytoskeleton-dependent cellular functions [5], we designed a
case-control genetic association study involving 208 prospectively collected cases of BU to dis-
sect the contribution of selected autophagy-related genes to the risk of disease and its distinct
phenotypes.
Materials and Methods
Patients and study design
The study population comprised 508 individuals from Zé District (Atlantique Department,
Benin), with 208 newly diagnosed BU patients recruited at the Centre de Deépistage et de Trai-
tement de l’Ulceère de Buruli d’Allada after 2005, and 300 unrelated, age and gender-matched
controls, with similar water contact habits and the same ethnic background (healthy endemic
controls) [1] (Table 1). This area presents a high incidence of BU, low consanguinity and uni-
form ethnicity [6]. All the subjects enrolled were HIV-negative and BCG-vaccinated. Collec-
tion of patient-level data included age, gender, clinical form, number and location of lesions
andWorld Health Organization (WHO) clinical classification—as a severity cataloguing. All
the patients enrolled were diagnosed after 2005, were positive for at least two of the three
WHO recommended diagnostic tests, and received appropriate treatment. The National Ethi-
cal Review Board of the Ministry of Health in Benin (IRB0006860) provided approval for this
study (clearance Nu 018, 20/Oct/2011), and written informed consent was obtained from all
adult participants. Parents or guardians provided informed consent on behalf of all child
participants.
Table 1. General characteristics of Buruli ulcer (BU) patients and healthy controls.
Variable BU (N = 208) Controls (N = 300) P value
Age, median (range) 14 (10–25) 17 (11–28) 0.247a
Gender, no (%)
Male 119 (57) 154 (51) 0.206b
Female 89 (43) 146 (49)
Clinical form, no. (%)
Ulcer (± osteomyelitis) 146 (70.2) - -
Plaque 48 (23) -
Oedema 12 (6) -
Nodule 2 (1) -
Site of lesion, no. (%)
Lower or upper limbs 181 (87) - -
Head or trunk 27 (13) -
WHO category, no (%)c
1 38 (18) - -
2 112 (54) -
3 58 (28) -
a P value is for Pearson’s χ2 test.
b P value is for Mann-Whitney U test.
c The WHO category of BU lesions was deﬁned according to standard criteria as follows: category 1, maximum lesion diameter <5 cm; category 2,
maximum lesion diameter 5–15 cm; and category 3, minimum lesion diameter >15 cm associated or not with osteomyelitis and/or multifocal lesions and/or
at a critical site.
doi:10.1371/journal.pntd.0004671.t001
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Genotyping
Genomic DNA from whole blood samples from patients and donors was isolated using the
NZY Blood gDNA Isolation kit (NZYTech) according to the manufacturer's instructions. SNPs
were selected based on previous published evidence of association with susceptibility to other
mycobacterial diseases (S1 Table), with a particular emphasis on genetic variants with well-
described functional consequences. Specifically, genetic variants in the multi-step intracellular
xenophagy recognition process of mycobacteria through the NOD2-ATG16L1 axis and the
complementary parkin-mediated ubiquitination were selected, thereby reinforcing the proba-
bility to detect positive associations. Genotyping of PARK2 (rs1333955, rs1040079, and
rs1514343), NOD2 (rs13339578, rs2066842, rs4785225, rs9302752, and rs5743278), and
ATG16L1 (rs2241880) SNPs was performed using the KASPar genotyping chemistry (LGC
Genomics, UK) following the manufacturer’s instructions.
Statistical analysis
The associations between SNPs and BU was performed using Pearson's χ2 test providing a
value of odds ratio (OR) with a 95% confidence interval (CI) for different genetic models (co-
dominant, dominant and recessive). A P value lower or equal to 0.05 was considered signifi-
cant. The linkage disequilibrium (LD) and Hardy-Weinberg equilibrium (HWE) tests were
assessed by using the Haploview 4.2 software. Genotype frequencies were used to phase the
haplotype configurations by resorting to the same software.
Results
A total of 208 newly diagnosed cases of BU and 300 unrelated controls were selected according
to fulfillment criteria. Demographics and clinical features of cases and age- and gender-
matched controls are summarized in Table 1. The median age of cases was 14 years [interquar-
tile range (IQR): 10–25] and similar to that of controls [17 years (IQR: 11–28)]; P = 0.25. The
gender distribution of cases and controls was also not significantly different [89 (43%) females
in 208 cases; and 146 (49%) females in 300 controls; P = 0.21]. Clinical features were in concor-
dance with general African characteristics of BU [1]. The dominant clinical form reported was
the ulcer (70.2%, including 6 cases with osteomyelitis), the mainly affected site were the limbs
(87%), and the WHO categories 1 to 3 were displayed in 18.3%, 53.8% and 27.9% of the cases,
respectively. The minor allele frequencies and HWE values for all SNPs are shown in S1 Table.
To assess the risk and progression of BU according to NOD2, PARK2 and ATG16L1 SNPs,
we compared their genotype frequencies between BU patients and age- and gender-matched
healthy controls. Whereas no significant variations in the distribution of genotypes among
cases and controls were observed in the overall test of association, the rs1333955 SNP in the
PARK2 gene was significantly associated with increased susceptibility to BU upon modelling of
a dominant mode of inheritance [OR, 1.43 (95% CI, 1.00–2.06); P = 0.05] (Table 2). Of interest,
a similar though less significant association was also observed for patients carrying the
rs1040079 SNP in the same gene [OR, 1.45 (95% CI, 0.96–2.18); P = 0.07]. Although the
rs1333955 SNP was found to be in strong LD with rs1514343 and rs1040079 (Fig 1), none of
the four haplotypes determined was significantly associated with the development of BU (S2
Table). No associations with the risk of BU were detected for SNPs in NOD2 or ATG16L1 (S3
Table). In addition, and although the rs13339578 SNP in the NOD2 gene was in strong LD
with both rs5743278 and rs4785225 SNPs (Fig 1), no associations were found for the haplo-
types formed by this block (S4 Table).
Since the clinical presentation of BU varies dramatically and epidemiological data has
pointed out that host genetic factors may be involved in these phenotypes [1], we further
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evaluated the genetic susceptibility to the severe WHO category 3 or the ulcerative form of BU.
We found that both the rs9302752 and rs2066842 (P268S) SNPs in the NOD2 gene signifi-
cantly increased the predisposition of patients to develop category 3 lesions following a domi-
nant genetic model [OR, 2.23 (95% CI, 1.14–4.37); P = 0.02; and OR, 12.7 (95% CI, 0.60–269);
P = 0.03), respectively] (Table 3). None of the other SNPs in NOD2, PARK2 or ATG16L1
revealed association with WHO category 3 (S5 Table). In what regards susceptibility to the
ulcerative form of BU disease, the rs2241880 (T300A) SNP in the ATG16L1 gene was found to
significantly protect patients from presenting the ulcer phenotype when a recessive genetic
Table 2. Genotype distributions and association test results of SNPs in the PARK2 gene among BU patients and age- and gender-matched healthy
controls.
Gene SNP rs# Number Alleles: status a Genotype, n (%) b P value c
A/A A/a a/a Overall Recessive model Dominant model
PARK2 rs1333955 C>T
BU 107 (52.2) 83 (40.5) 15 (7.3) 0.113 0.24 0.05
Controls 177 (61.0) 99 (34.2) 14 (4.8)
rs1040079 G>A
BU 90 (30.4) 148 (50.0) 58 (19.6) 0.161 0.22 0.07
Controls 47 (23.2) 107 (52.7) 49 (24.1)
rs1514343 G>A
BU 70 (33.7) 109 (52.4) 29 (13.9) 0.314 0.13 0.78
Controls 97 (32.4) 145 (48.5) 57 (19.1)
a The ﬁrst nucleotide represents the major allele.
b Genotypes were deﬁned according to the major (A) and minor (a) alleles at each SNP.
c Association tests for the overall association (A/A vs. A/a vs. a/a), and the recessive (A/A + A/a vs. a/a) and dominant (A/A vs. A/a + a/a) genetic models
were carried out using Fisher’s exact t test.
doi:10.1371/journal.pntd.0004671.t002
Fig 1. Haploview pairwise analysis of Linkage Disequilibrium (LD) between NOD2 gene SNPs (A) and
PARK2 gene SNPs (B). The r2 colour scheme was used. Measures of r2 = 0 are represented in white (not
significant); 0<r2<1 are represented in shades of grey; r2 = 1 are represented in black (significant). The
numbers inside the box indicate the r2 in a percentage version. An r2 of 0 indicates complete linkage
equilibrium, whereas an r2 of 1 indicates complete LD.
doi:10.1371/journal.pntd.0004671.g001
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model was applied [OR, 0.35 (95% CI, 0.13–0.90); P = 0.02] (Table 3). None of the other SNPs
in PARK2 or NOD2 genes revealed associations with the degree of ulceration (S5 Table).
Discussion
We compared the prevalence of SNPs in autophagy-related genes in confirmed cases of BU
and in randomly selected community controls equally exposed to similar risk factors such as
relationship and same behaviors (recreational or not) related to stagnant waters around
villages.
Table 3. Genotype distributions and association test results of SNPs in theNOD2 and ATG16L1 genes with the severeWHO category 3 or the
ulcerative form of BU disease.
Gene SNP rs# number Allelesa: status Genotype, n (%)b P valuec
A/A A/a a/a Overall Recessive model Dominant model
NOD2 rs9302752 C>T
Cat. 1 or 2 63 (43.8) 60 (41.7) 21 (15.6) 0.05 0.64 0.02
Cat. 3 15 (25.9) 33 (56.9) 10 (17.2)
Non-ulcerative 24 (38.7) 28 (45.2) 10 (16.1) 1.00 0.86 0.94
Ulcerative 57 (39.3) 66 (45.5) 22 (15.2)
rs13339578 A>G
Cat. 1 or 2 42 (29.2) 68 (47.2) 34 (23.6) 0.54 0.27 0.82
Cat. 3 16 (27.6) 24 (41.4) 18 (31.0)
Non-ulcerative 17 (27.4) 27 (43.6) 18 (29.0) 0.76 0.46 0.67
Ulcerative 44 (30.4) 66 (45.5) 35 (24.1)
rs2066842 C>T
Cat. 1 or 2 143 (100) 0 (0.0) 0 (0.0) 0.08 1.00 0.03
Cat. 3 56 (96.6) 2 (3.4) 0 (0.0)
Non-ulcerative 62 (100) 0 (0.0) 0 (0.0) 1.00 1.00 0.35
Ulcerative 142 (98.6) 2 (1.4) 0 (0.0)
rs5743278 C>G
Cat. 1 or 2 131 (90.3) 14 (9.7) 0 (0.0) 0.35 0.11 0.82
Cat. 3 53 (91.4) 4 (9.1) 1 (1.7)
Non-ulcerative 54 (87.1) 7 (11.3) 1 (1.6) 0.21 0.12 0.29
Ulcerative 134 (91.8) 12 (8.2) 0 (0.0)
rs47885225 G>C
Cat. 1 or 2 41 (28.5) 68 (47.2) 35 (24.3) 0.60 0.33 0.90
Cat. 3 16 (27.6) 24 (41.4) 18 (31.0)
Non-ulcerative 16 (25.8) 28 (45.2) 18 (29.0) 0.73 0.53 0.51
Ulcerative 44 (30.3) 65 (44.9) 36 (24.8)
ATG16L1 rs2241880 T>C
Cat. 1 or 2 76 (52.8) 55 (38.2) 13 (9.0) 0.36 0.74 0.17
Cat. 3 24 (42.1) 27 (47.4) 6 (10.5)
Non-ulcerative 27 (43.6) 25 (40.3) 10 (16.1) 0.07 0.02 0.22
Ulcerative 76 (52.8) 59 (41.0) 9 (6.2)
a The ﬁrst nucleotide represents the major allele.
b Genotypes were deﬁned according to the major (A) and minor (a) alleles at each SNP.
c Association tests for the overall association (A/A vs. A/a vs. a/a), and the recessive (A/A + A/a vs. a/a) and dominant (A/A vs. A/a + a/a) genetic models
were carried out using Fisher’s exact t test.
doi:10.1371/journal.pntd.0004671.t003
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We found that the rs1333955 SNP in the PARK2 gene was significantly associated with
development of BU. The PARK2 protein—known as parkin—is associated with the process of
protein ubiquitination, acting as an E3 ligase and targeting proteins for proteasomal degrada-
tion [7]. The ubiquitin-mediated pathway is a complementary system for autophagy activation
and that contributes to pathogen elimination, includingM. tuberculosis, by surrounding bacte-
ria with conjugated ubiquitin chains. Our findings support a role for the PARK2/PACRG gene
cluster in susceptibility toM. ulcerans infection, suggesting that mechanisms linked to ubiquiti-
nation and proteasome-mediated protein degradation might unveil a common pathway in the
intracellular fate of this pathogen. The fact that the same SNP has been associated with a higher
risk of leprosy [8] points to a pertinent role for this gene in both infections. In addition,
PACRG has been suggested to preferentially bind to hydrophobic molecules, such as lipids [9].
Mycolactone, a lipid mycotoxin, was recently shown to inhibit translocation of newly trans-
lated proteins into the endoplasmic reticulum [10], culminating in their degradation by the
proteasome. Accordingly, we have recently reported that mycolactone induces an increased
amount of ubiquitinated proteins in the cell by affecting cytoskeleton constituents and cyto-
skeleton-dependent intracellular trafficking [5]. Ultimately, this points to likely critical conse-
quences of the rs1333955 SNP on the proteasomal degradation induced by mycolactone and
might explain, at least in part, its association with risk of BU.
Because autophagy is a pivotal immunological mechanism mediating protection to infection
by intracellular pathogens [4], mycolactone-induced impairment of autophagy might have
implications for the progression of BU disease. Previous studies have revealed that the
NOD2-ATG16L1 axis is important for maintaining intracellular immune homeostasis [11].
The rs9302752 and rs2066842 SNPs in the NOD2 gene were found to be significantly associ-
ated with a severe phenotype of BU disease, reflected by the WHO Category 3, suggesting a
crucial role of genetic variability of the NOD2 locus in defining severity of BU disease. The
rs9302752 SNP is located in the upstream region of the gene, and therefore it might deregulate
promoter activity and influence gene expression and susceptibility to infection. Indeed, silenc-
ing NOD2 expression in human macrophages was reported to result in a local spread ofM.
tuberculosis, with an impairment in NOD2-mediated production of cytokines [12]. In addition,
the rs2066842 SNP underlies the P268S amino acid substitution, and has been found to affect
host recognition of bacterial muramyl dipeptide. As such, we hypothesize that a failure in the
innate immune recognition ofM. ulcerans via NOD2 might divert the proper activation of
immunological autophagy, therefore permitting progression of infection and development of
more severe phenotypes.
The non-ulcerative and ulcerative forms of BU can be observed as stable clinical pheno-
types, and not all patients progress to the latter [1]. We found the rs2241880 SNP in the
ATG16L1 gene to be associated with protection of BU patients from an ulcerative clinical form.
ATG16L1 is a master regulator of the core autophagy machinery that was initially identified as
a pivotal risk factor for Crohn’s disease [13]. The rs2241880 variant is located in the coding
region of ATG16L1 and leads to the Thr300Ala (T300A) amino acid substitution, which has
recently been found to enhance its self-degradation by caspase 3, thereby impairing autophagy
activation [14]. Of interest, the T300A variant also decreased selective autophagy, resulting in
increased interleukin (IL)-1β signaling and decreased antibacterial defense [14]. Increased lev-
els of IL-1β are also associated with a more exuberant local inflammation. Indeed, non-ulcera-
tive forms of BU, such as edema and plaque, are considered more inflammatory than ulcerative
lesions [15].
Our study has some limitations. In particular, the study was conducted in a single popula-
tion, and therefore it requires confirmation in larger groups and independent cohorts, as well
as the assessment of the functional consequences of the associated variants and their influence
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to the immune response dynamics. It is however important to note that our case-control study
has a robust sample size and the critical advantage that controls were carefully matched to
cases regarding environmental exposure to mycobacteria.
Our findings indicate that specific genetic variants in autophagy-related genes influence sus-
ceptibility to the development of BU and its progression to severe phenotypes, highlighting the
multiple additive effects of single genetic factors and their complex interactions towards the
overall weight of the human immune response toM. ulcerans. Ultimately, this study reinforces
the applicability of host genomics as an important factor to be considered in the stratification
of infection risk in endemic regions and, more importantly, for the definition of patient groups
more likely to advance to more severe and debilitating phenotypes of BU disease.
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